Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study.
Uros MarkovicAlessandra RomanoClaudia BellofioreAnnalisa CondorelliBruno GaribaldiAnna BullaAndrea DuminucoVittorio Del FabroFrancesco Di RaimondoConcetta ConticelloPublished in: Cancers (2021)
Alterations of sFLC values, namely iFLC and FLCr, both prior to treatment initiation and in the course of therapy at every treatment line, could be of aid in relapse evaluation and treatment outcome. We therefore suggest close periodical monitoring of sFLC assay, independently from secretory status.